Online Q&A on the collaboration between GARDP and Venatorx Pharmaceuticals to accelerate the development of, and access to, cefepime-taniborbactam, as well as the urgent need for new treatments for drug-resistant infections in healthcare settings.
Dr Manica Balasegaram, Executive Director, GARDP
Dr Christopher Burns, President and CEO, Venatorx Pharmaceuticals
Dr Yogandree Ramsamy, Pathologist, South Africa National Health Laboratory Services
Moderator: Jennifer Katz, Director of External Affairs, GARDP